These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38591163)

  • 41. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma.
    Cen X; Li M; Yao A; Zheng Y; Lai W
    J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of sterile a-motif domain-containing 9-like as a potential biomarker in patients with cutaneous melanoma.
    Ye J; Tang H; Xie C; Han W; Shen G; Qian Y; Xu J
    PeerJ; 2023; 11():e15634. PubMed ID: 37426410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma.
    Zhao S; Wen S; Liu H; Zhou Z; Liu Y; Zhong J; Xie J
    Front Surg; 2022; 9():917776. PubMed ID: 36034394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
    Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
    Front Immunol; 2022; 13():914108. PubMed ID: 36032150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma
    Zhou S; Han Y; Li J; Pi X; Lyu J; Xiang S; Zhou X; Chen X; Wang Z; Yang R
    Front Oncol; 2021; 11():745384. PubMed ID: 34722301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
    Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
    Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients.
    Pang H; Zhou Y; Wang J; Wu H; Cui C; Xiao Z
    Transl Oncol; 2022 Jan; 15(1):101253. PubMed ID: 34737118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression.
    Zhang K; Yu C; Tian R; Zhang W; Tang S; Wang G
    Mol Biol Rep; 2022 Oct; 49(10):9137-9145. PubMed ID: 36057879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma.
    Wang Y; Zhang H
    Front Mol Biosci; 2022; 9():805887. PubMed ID: 35300113
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploring the impact of TGF-β family gene mutations and expression on skin wound healing and tissue repair.
    Cui K; Gong S; Bai J; Xue L; Li X; Wang X
    Int Wound J; 2024 Apr; 21(4):e14596. PubMed ID: 38151761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
    He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
    Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
    J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruptions of Circadian Genes in Cutaneous Melanoma-An In Silico Analysis of Transcriptome Databases.
    Lesicka M; Nedoszytko B; Reszka E
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
    Ren TY; Zhang YX; Hu W
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA FENDRR inhibits migration and invasion of cutaneous malignant melanoma cells.
    Chen XE; Chen P; Chen S; Lu J; Ma T; Shi G; Sheng L
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32134466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bmal1 upregulates ATG5 expression to promote autophagy in skin cutaneous melanoma.
    Lei T; Cai X; Zhang H; Wu X; Cao Z; Li W; Xie X; Zhang B
    Cell Signal; 2024 Sep; 124():111439. PubMed ID: 39343115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.